**Core Concept**
Radical retroperitoneal lymph node dissection (RPLND) is a surgical procedure aimed at removing lymph nodes in the retroperitoneum, where testicular cancer often spreads. This procedure is crucial for patients with non-seminomatous germ cell tumors (NSGCTs), which include teratoma, teratocarcinoma, and choriocarcinoma.

**Why the Correct Answer is Right**
Seminomas are a type of germ cell tumor that typically respond well to radiotherapy and chemotherapy. In contrast, RPLND is usually reserved for patients with NSGCTs, as these tumors are more likely to have spread to the lymph nodes. Seminomas are less aggressive and have a better prognosis, making surgery less necessary. The standard treatment for seminoma involves orchiectomy followed by radiotherapy or chemotherapy, depending on the stage and risk factors.

**Why Each Wrong Option is Incorrect**
**Option A:** Choriocarcinoma is a type of NSGCT that often requires RPLND as part of the treatment plan, making it an incorrect option.

**Option B:** Teratoma is a type of NSGCT that may require RPLND, especially if it contains mature elements or if the tumor is large. This makes it an incorrect option.

**Option C:** Teratocarcinoma is another type of NSGCT that often requires RPLND, as it has a high risk of lymph node involvement. This makes it an incorrect option.

**Clinical Pearl / High-Yield Fact**
It's essential to remember that RPLND is typically reserved for patients with NSGCTs, whereas seminomas are usually treated with radiotherapy or chemotherapy. This distinction is critical in determining the appropriate treatment plan for patients with testicular cancer.

**Correct Answer:**
✓ Correct Answer: D. Seminoma